News
A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their ...
Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...
Louis J. Aronne, principal investigator on the SURMOUNT-5 clinical trial, said the results "demonstrated tirzepatide (Zepbound) led to greater weight reduction compared to semaglutide (Wegovy), ...
President Trump's new Executive Order aims to lower prescription drug prices by tying U.S. costs to global rates. Read more ...
Novo Nordisk cut 2025 sales forecast citing competition from compounded versions of its Wegovy weight-loss drug. Invezz takes ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...
Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...
It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...
Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results